Department of Biomedical and Molecular Biology  
Department Description
Graduate Studies
Departmental Courses
Faculty and Personnel
  Faculty
Home Page
  Research Focus
  Publications
  Lab Members
  Web Links
 
Seminars and other Events

Links
Contact Us
Dr. Shile Huang's Selected Publications
  1. Houghton PJ, Huang S. mTOR as a target for cancer therapy. Curr Top Microbiol Immunol. 279:339-359, 2004.
  2. Huang S, Houghton PJ. Targeting mTOR signaling for cancer therapy. Curr Opin Pharmacol. 3:371-377, 2003.
  3. Huang S, Bjornsti MA, Houghton PJ. Rapamycins: mechanism of action and cellular resistance. Cancer Biol Ther. 2:222-232, 2003.
  4. Huang S, Shu L, Dilling MB, Easton J, Harwood FC, Ichijo H, Houghton PJ. Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21Cip1. Mol Cell. 11(6):1491-1501, 2003.
  5. Thimmaiah KN, Easton J, Huang S, Veverka KA, Germain GS, Harwood FC, Houghton PJ. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways. Cancer Res. 63:364-374, 2003.
  6. Huang S, Houghton PJ. Mechanisms of resistance to rapamycins. Drug Resist Updat. 4:378-391, 2001.
  7. Huang S, Houghton PJ. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Curr Opin Investig Drugs. 3:295-304, 2002.
  8. Huang S, Houghton PJ. Resistance to rapamycin: a novel anticancer drug. Cancer Metastasis Rev. 20:69-78, 2001.
  9. Huang S, Liu LN, Hosoi H, Dilling MB, Shikata T, Houghton PJ. p53/p21CIP1 cooperate in enforcing rapamycin-induced G1 arrest and determine the cellular response to rapamycin. Cancer Res. 61:3373-3381, 2001.
Department Description | Graduate Studies | Departmental Courses | Faculty & Personnel
Seminars & other Events | Links | Greater Shreveport Area | Contact Us